DWTX

Dogwood Therapeutics, Inc.

$1.49 -0.01 (-0.67%) At close · Jul 2

Market Cap

$50.11M

33,629,553

Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.

Date	Insider	Role	Type	Shares	Price	Value	After
2026-06-16	Keefer David R	Director	Award	16,800	—	—	16,800
2026-06-16	Thomas John C	Director	Award	16,800	—	—	16,800
2026-06-16	Whitley Richard James	Director	Award	16,800	—	—	16,800
2026-06-16	De La Rosa Abel	Director	Award	16,800	—	—	16,800
2026-03-05	Duncan Gregory Scott	Director, CHIEF EXECUTIVE OFFICER	Award	330,000	—	—	330,000
2026-03-05	Gendreau Roger Michael	CHIEF MEDICAL OFFICER	Award	82,500	—	—	82,500
2026-03-05	Walsh Angela	Chief Financial Officer	Award	82,500	—	—	82,500
2026-03-05	Grosswald Ralph	SVP OF OPERATIONS	Award	82,500	—	—	82,500
2025-12-04	Gendreau Roger Michael	CHIEF MEDICAL OFFICER	Award	150,000	—	—	150,000
2025-12-04	Walsh Angela	Chief Financial Officer	Award	150,000	—	—	150,000
2025-12-04	Grosswald Ralph	SVP OF OPERATIONS	Award	150,000	—	—	150,000
2025-12-04	Duncan Gregory Scott	Director, CHIEF EXECUTIVE OFFICER	Award	460,000	—	—	460,000
2025-11-21	Sealbond Ltd	Director, 10% Owner	Other	284	—	—	0
2025-11-21	Sealbond Ltd	Director, 10% Owner	Other	2,161	—	—	0
2025-11-21	Sealbond Ltd	Director, 10% Owner	Other	21,610,950	—	—	21,822,333
2025-11-21	Sealbond Ltd	Director, 10% Owner	Other	2,842,638	—	—	2,842,638
2025-06-27	Whitley Richard James	Director	Award	2,362	—	—	2,362
2025-06-27	De La Rosa Abel	Director	Award	2,362	—	—	2,362
2025-06-27	Thomas John C	Director	Award	2,362	—	—	2,362
2025-06-27	Grosswald Ralph	SVP OF OPERATIONS	Award	12,075	—	—	12,075
2025-06-27	Duncan Gregory Scott	Director, CHIEF EXECUTIVE OFFICER	Award	40,000	—	—	40,000
2025-06-27	Walsh Angela	Chief Financial Officer	Award	12,075	—	—	12,075
2025-06-27	Keefer David R	Director	Award	2,362	—	—	2,362
2025-06-27	Gendreau Roger Michael	CHIEF MEDICAL OFFICER	Award	12,075	—	—	12,075
2025-06-18	Whitley Richard James	Director	Award	210	—	—	210
2025-06-18	Keefer David R	Director	Award	210	—	—	210
2025-06-18	Keefer David R	Director	Award	210	—	—	420
2025-06-18	Whitley Richard James	Director	Award	210	—	—	420
2025-06-18	Thomas John C	Director	Award	210	—	—	210
2025-06-18	Thomas John C	Director	Award	210	—	—	420
2025-06-18	De La Rosa Abel	Director	Award	210	—	—	420
2025-06-18	De La Rosa Abel	Director	Award	210	—	—	210
2025-03-12	CK Life Sciences Intl (Holdings) Inc	Director, 10% Owner	Award	284	$7.01	$1,991	284
2024-10-07	Yu Ying Choi Alan Abel	Director	Other	0	—	—	0
2024-10-07	Toh Kean Meng Melvin	Director	Other	0	—	—	0
2024-02-26	Grosswald Ralph	SVP OF OPERATIONS	Award	62,568	—	—	62,568
2024-02-26	Gendreau Roger Michael	CHIEF MEDICAL OFFICER	Award	88,085	—	—	88,085
2024-02-26	Pridgen William	Director	Award	2,917	—	—	2,917
2024-02-26	De La Rosa Abel	Director	Award	3,959	—	—	3,959
2024-02-26	Whitley Richard James	Director	Award	4,000	—	—	4,000
2024-02-26	Duncan Gregory Scott	Director, CHIEF EXECUTIVE OFFICER	Award	138,835	—	—	138,835
2024-02-26	Thomas John C	Director	Award	4,167	—	—	4,167
2024-02-26	Burch Richard Alan	Director	Award	2,917	—	—	2,917
2024-02-26	Keefer David R	Director	Award	4,709	—	—	4,709
2024-02-26	Walsh Angela	Chief Financial Officer	Award	63,618	—	—	63,618
2023-08-21	Pridgen William	Director	Buy	15,335	$1.30	$19,992	52,045
2023-08-17	Duncan Gregory Scott	Director, CHIEF EXECUTIVE OFFICER	Buy	25,000	$1.25	$31,245	57,461
2023-06-15	De La Rosa Abel	Director	Award	5,250	—	—	5,250
2023-06-15	Pridgen William	Director	Award	5,250	—	—	5,250
2023-06-15	Burch Richard Alan	Director	Award	5,250	—	—	5,250

Showing 1–50 of 118 transactions

Key facts CIK 1818844 CUSIP 92829J203 Visit website Investor relations